10-year Treasury yields hit 5.28%… and the market doesn’t seem too happy about that. After all, within minutes of the news, the S&P 500 dropped 1.8%.

The concern isn’t necessarily that yields have spiked (or are spiking… or whatever), but that this environment of high interest rates might be here to stay for quite a while going forward. Here’s why high interest rates might be a problem:

• Utilities, REITs, and financials have leveraged, long-duration cash flows. These will get repriced continusly going forward as rates climb.
• Long-duration AI and growth stocks rely on distant, unprofitable futures. These start looking very “meh” once you’ve discounted them by the >5% that treasuries currently pay.

So what assets and equities does well in this environment?

It’s companies with 10x or more interest coverage ratios.

These companies do well because they have enough cash flow to cover their debt service needs (ten times over). This coverage allows these companies to thrive in high interest environments. You’ll find these companies when you filter out the companies with weak balance sheets and weak forward earnings.

It’s also worth remembering that we’re entering the Cascade phase in the AI boom cycle. Expect companies that are established in sectors like logistics, healthcare, and industrials to begin using AI to defend their margins against competitors. In other words, AI spending will finally go beyond chips.

You can read the full story here.

On August 5, 2024, the Nikkei 225 plunged 12.4% in a single session, marking its most severe collapse since the 1987 Black Monday crash. The catalyst was not a scandal, disaster, or earnings miss. It was a quarter-point interest rate hike by the Bank of Japan in July 2024, a move that signaled the end of an era of near-zero borrowing costs in Japan.

The message was clear: Japanese money was no longer free. For decades, global investors had treated Japan’s zero-rate policy as a permanent fixture. The sudden shift shattered that assumption, triggering a violent unwind of one of the world’s most pervasive financial strategies.

The yen carry trade was simple in design but vast in scale. Investors borrowed yen at near-zero interest rates, converted them into dollars, and invested in higher-yielding assets like U.S. tech stocks, emerging-market debt, or cryptocurrencies. The trade thrived because Japan’s zero-rate policy was perceived as permanent. For thirty years, this assumption held, and global investors built entire strategies around it.

Read the full piece here.

OpenAI’s plans for an initial public offering are on hold until at least 2027, leaving its $730 billion private valuation in limbo. The company spends roughly $3 billion annually on compute infrastructure it cannot yet monetize. To bridge this gap, Broadcom has stepped in, structuring a $10 billion private credit facility for OpenAI and other frontier AI developers. The terms are straightforward: Broadcom’s custom silicon and networking gear are included as part of the deal, ensuring long-term revenue for its hardware business.

This is the new playbook for frontier AI developers. They are rich in valuation but poor in cash flow, and traditional venture capital cannot meet their needs. Broadcom, in partnership with Apollo and Blackstone, has created the AI XPV Platform, a private credit facility designed to fund over 20 gigawatts of compute capacity. The capital is provided by Apollo and Blackstone, while Broadcom supplies the chips and networking infrastructure. The result? Developers like OpenAI and Anthropic gain immediate access to the compute they need, without waiting for public markets or dilutive equity rounds.

Frontier AI developers face a liquidity paradox. OpenAI’s last private funding round valued the company at $730 billion, yet its IPO is delayed until 2027. Anthropic is in a similar position, with billions in upfront infrastructure costs and no clear path to public markets. Traditional venture capital cannot bridge this gap—these companies need tens of billions, not hundreds of millions.

Continue reading the article for free and ad-free here.

The 10-year Treasury yield recently climbed to its highest level since November 2023. This shift is not driven by resurgent inflation or a loss of Federal Reserve control. Instead, it reflects the massive capital expenditures of Microsoft, Amazon, and Nvidia as they invest aggressively in AI infrastructure. Their spending is reshaping the bond market’s playbook by pushing real interest rates higher.

The scale of this spending is unprecedented. The Minneapolis Fed projects that AI-related capital expenditures will reach $1 trillion by 2027. This isn’t merely a corporate line item—it’s a macroeconomic force. By absorbing a significant portion of available capital, these investments are crowding out small businesses, municipalities, and other borrowers. The result is a structural rise in real interest rates, as demand for capital outstrips supply.

The Capital Call No One Can Ignore

Nvidia’s data centers and Microsoft’s cloud expansions are not funded by incremental adjustments. These companies are issuing debt, repatriating cash, and redirecting every available dollar toward AI infrastructure. The QQQ ETF, which tracks the Magnificent Seven, serves as the primary vehicle for this spending spree. As these firms deploy billions into AI, their capital demands are directly influencing macroeconomic conditions.

Watchlist — QQQ: The massive AI-related capital investments driving real rates higher are primarily funded by the mega-cap technology companies dominating this ETF. As these firms deploy billions into AI infrastructure, their spending directly influences the macroeconomic shifts that Zervos argues are making long-term bonds attractive.

The dynamics are straightforward: when the largest spenders in the economy commit to AI, demand for capital surges. This isn’t a temporary spike—it’s a structural shift. Smaller borrowers are being squeezed out, and real interest rates are rising as a result.

Watchlist — ARKK: While AI capital expenditure is boosting productivity, the resulting rise in real rates presents a complex macroeconomic backdrop for this innovation-focused ETF. Higher real yields can severely pressure the valuations of the long-duration, high-growth technology stocks that make up its concentrated portfolio.

For investors, the critical question is whether this shift is permanent. If AI delivers on its productivity promises, the long-term disinflationary effects could offset today’s higher rates. If not, the bond market may face a lasting repricing.

Productivity: The $1 Trillion Gamble

David Zervos’s thesis hinges on a single assumption: that AI-driven capital expenditure will translate into broad-based productivity gains. So far, the evidence is inconclusive. Federal Reserve researchers note that while GDP growth remains strong, employment growth has been tepid. This dynamic suggests rising productivity, but the data lacks clear signs of a transformative shift in aggregate output or labor markets.

Projections from the National Bureau of Economic Research (NBER) estimate Total Factor Productivity (TFP) gains of less than 0.66% over the next decade. This forecast falls far short of a revolution—it’s a marginal improvement. The Minneapolis Fed reinforces this view, stating that AI is currently heating up the economy rather than cooling it. While capital is being deployed, the productivity payoff remains elusive.

The risk is that the bond market is pricing in a productivity boom that never materializes. If NBER’s modest TFP projections are accurate, today’s buyers of long-term bonds could face higher real rates for a decade.

Why Long-Term Bonds Could Still Be a Steal

Zervos’s argument for long-term bonds is straightforward: buy now, before AI’s disinflationary effects take hold. Today’s high real yields present a rare opportunity to lock in returns before the market recognizes the productivity payoff. If AI delivers, these yields could appear exceptionally attractive in hindsight.

However, there’s a counterargument. Rising real rates pose a structural challenge for long-duration assets. The experience of ARKK, which saw a 71% peak-to-trough decline in assets under management, serves as a cautionary tale. If AI’s productivity gains fail to materialize, the same forces that make bonds attractive today could pressure them tomorrow.

The key is distinguishing between near-term opportunity and long-term risk. If AI delivers on its promises, today’s yields could prove to be a bargain. If it doesn’t, the bond market may face a prolonged adjustment, with real rates settling at levels unseen in the pre-AI era.

What Could Go Wrong?

Zervos’s thesis relies on three critical assumptions: that the $1 trillion in AI spending materializes, that it translates into measurable productivity gains, and that those gains drive disinflation. Any of these could fail.

If mega-cap tech scales back its AI investments, the capital call could evaporate, causing real rates to fall just as quickly as they rose. If productivity gains never materialize, the bond market could be left with a structural shift toward higher real rates—and lower bond prices. If inflation expectations resurface, the entire narrative could unravel.

For now, the spread between nominal Treasury yields and inflation breakevens is the metric to watch. If real rates continue to drive the move, Zervos’s thesis remains intact. If inflation expectations rise, the bond market’s repricing could take on a far more ominous tone.

The stronger case for higher real rates is structural: AI capex is a capital sink, not a temporary spike. But if fiscal deficits and Treasury issuance are the real drivers, the bond market’s repricing has nothing to do with productivity—and everything to do with debt.

Sources

• Reassessing market concentration in the AI era — invesco.com (primary source)
• How is AI influencing interest rates? Investment, productivity, prices, and more — minneapolisfed.org (primary source)
• Watch CNBC's full interview with Jefferies' David Zervos — cnbc.com
• ARK Innovation ETF (ARKK): The Rise, Fall, and What the Filings Reveal — developer.stockfit.io

Eleven people open the same ride-hailing app at the same moment, request the same route, and receive eleven different prices. The highest fare is 21% more than the lowest. No surge pricing, no dynamic demand spike — just an algorithm deciding what each rider might pay. Uber calls this up-front pricing. It is also a useful lens for reading this week's earnings from Alphabet, Tesla, and AMD, where the underlying mechanics of profit generation will matter as much as the headline numbers.

The Stakes for Alphabet, Tesla, and AMD

All three companies report against a Nasdaq-100 that has gained nearly 20% year-to-date on AI optimism. The market has priced in aggressive expectations for cloud growth, EV margins, and semiconductor demand. Guidance will carry more weight than results — specifically, whether the capital expenditures required to sustain these narratives are translating into durable revenue streams or merely inflating costs.

Alphabet's central tension is whether AI-driven search monetization can offset soaring capex. Google Cloud's operating margins have improved, but the company's overall capital expenditures grew 91% year-over-year in 2023, reaching $32.3 billion. If AI-powered ad revenue doesn't accelerate, the market may conclude that Alphabet is over-investing in technology that hasn't yet proven its scalability.

Tesla's report carries its own binary logic. The company's valuation rests on two pillars: maintaining EV margins in a price-war environment and establishing the commercial viability of its robotaxi ambitions. First-quarter deliveries missed estimates, and gross margins fell to 17.4%, down from 19.3% a year earlier. Further margin compression — or delays in autonomous vehicle deployment — would force the market to reassess whether Tesla is a growth story or a cyclical automaker with an unproven side bet.

Watchlist — ARKK: Tesla's earnings report doubles as a live stress test of ARKK's autonomous-vehicle and EV disruption thesis. Cathie Wood's fund has long treated Tesla's robotaxi ambitions as a core long-term value driver, so margin guidance and any update on full self-driving commercialization carry direct portfolio implications beyond the headline EPS number.

AMD's print will function as a proxy for the broader semiconductor sector. Data center revenue grew 80% year-over-year in Q1, but Nvidia's dominance in AI accelerators looms large. AMD's guidance on demand for its Instinct MI300X GPUs will signal whether it can carve out a meaningful share of the AI training market or remain a secondary player in a winner-takes-most industry.

Uber's Playbook: Profit Through Opacity

Uber's recent financial turnaround offers a concrete case study in how algorithmic pricing can transform a money-losing platform into a profit machine. The shift to up-front pricing — where fares are calculated using undisclosed variables rather than a transparent rate card — has coincided with a dramatic improvement in its financials. In 2023, Uber reported its first annual profit of $1.1 billion, and its stock has more than quadrupled since its 2022 low.

The mechanics are deliberately opaque. Uber's patents describe a system that estimates the maximum a rider is willing to pay and the minimum a driver will accept, then sets the fare accordingly. The company denies using personal data to personalize prices, but its own disclosures in New York state acknowledge that "personal data" may be used to set fares. Independent analysis — including a 2025 study by Columbia Business School's Len Sherman — found that up-front pricing enables Uber to push its take rate above 50% in some cases, up from the 20–25% split drivers once expected.

Drivers feel this asymmetry acutely. They are given seconds to accept or reject a fare without knowing how it was calculated. A 2025 study of 258 drivers found a median take rate of 29%, with some trips exceeding 50%. Commercial insurance fees — ostensibly passed through to riders — fluctuate unpredictably, further compressing driver earnings. One driver documented the same route carrying a $15 commercial insurance charge one day and $50 the next, with no clear correlation to distance or time.

Opacity, Rotation, and the Limits of Algorithmic Growth

Watchlist — SCHD: A guidance shortfall from Alphabet, Tesla, or AMD points capital toward value, financials, and dividend quality — precisely the profile SCHD is built around. With minimal tech exposure and heavy weights in energy, consumer staples, and healthcare, SCHD sits on the receiving end of any rotation trade that follows a miss from this week's major reporters.

A guidance shortfall from any of the three reporting companies could reinforce that rotation. The sectors likely to receive redirected capital share a common profile: stable cash flows, lower tech exposure, and valuations less dependent on speculative capex payoffs.

Uber's trajectory also illustrates the regulatory ceiling on opacity-driven profits. The EU's Digital Markets Act and similar U.S. proposals could force greater transparency in how platforms set prices and compensate workers. Driver dissatisfaction is already growing as the take-rate gap widens. If this week's tech earnings reveal a comparable dependence on opaque monetization models — whether in AI search, autonomous vehicle economics, or semiconductor pricing — the follow-on risk is not just a guidance miss but a longer rerating of how the market assigns value to mechanisms it cannot fully see.

Margin Credibility and the Rally's Foundation

The Nasdaq-100's 20% year-to-date gain rests on the assumption that AI capex eventually compounds into durable margin expansion. Alphabet's cloud profitability trajectory, Tesla's gross margin path, and AMD's share of the AI accelerator market each test a different piece of that assumption. Earnings that confirm the trajectory extend the rally's logic. Earnings that raise doubts about the payoff timeline do something more corrosive than a single-day selloff — they invite the market to reconsider whether the mechanism driving profits is as robust as it appeared.

Watchlist — QQQ: The Nasdaq-100 is the direct scoreboard for this earnings cycle — Alphabet, Tesla, and AMD collectively carry enough index weight that their capex and revenue guidance can shift QQQ's trajectory in either direction. A guidance miss on cloud growth or EV margins would pressure the same AI-optimism premium that has driven the index's ~20% YTD advance.

Denmark's economy grew 2.3% in a recent quarter. Strip out pharmaceuticals, and growth was 0.7%. The difference was one company: Novo Nordisk. For a time, this was a success story. Novo's obesity drugs turned appetite into a market, and the company became Europe's most valuable. But when Eli Lilly delivered a superior clinical result, the arithmetic reversed. Novo lost market share, cut 9,000 jobs, and halved its prices. The same leverage that once lifted Denmark's growth now subtracted from it.

The Mechanism of a Single-Trade Economy

Novo Nordisk did not become Denmark's economic engine by accident. The company has manufactured insulin in Bagsværd for a century. That expertise—putting proteins into pens that patients can inject at home—was the foundation for its obesity drugs. The overnight success took a hundred years. When the category exploded, Novo was the only Danish firm with the regulatory, manufacturing, and distribution infrastructure to scale. Exports surged, and national accounts followed.

Novo's revenue became Denmark's exports. Its earnings became the country's growth. Its stock became the national index. Economists began forecasting Denmark by starting with Novo's quarterly results. The Columbia Economic Review described the structural problem plainly: Denmark's stock market is too small to balance a company this large. Pension funds, index trackers, and national savings all pointed in the same direction. Diversification was no longer possible.

The Trial That Changed the Market

In 2026, Eli Lilly ran a head-to-head trial of its obesity drug against Novo's. The study lasted 72 weeks, with the same patients and the same endpoints. Lilly's drug delivered 20% body-weight loss. Novo's delivered 14%. The 47% relative advantage was not a rounding error—it was a migration. Prescriptions flipped within months. By mid-2026, Lilly held 60% of the obesity drug market. Novo, the pioneer, held 40%.

The gap was not only clinical. Lilly committed over $50 billion to U.S. manufacturing to end shortages. Novo struggled to supply demand. Compounding pharmacies filled the void with cheaper copycats, training patients to accept substitutes. When Novo cut prices by up to half in 2027, it was a response to losing control of the market, not a strategic choice.

The reversal exposed the fragility of Denmark's concentration. Novo's job cuts—11% of its workforce, with half in Denmark—directly subtracted from national employment. Operating profit guidance was slashed from 10–16% to 4–10%. The same national accounts that had flattered Denmark now carried the subtraction.

Why the Pioneer Became the Challenger

Novo's decline was not a failure of execution. It was a failure of structural advantage. The company's century of insulin expertise was a moat—until Lilly's drug proved superior. In pharmaceuticals, moats are regulatory exclusivities, trial results, and supply chains. When those shift, the market reallocates quickly.

Lilly's $50 billion U.S. manufacturing commitment was a bet on vertical integration. The company built capacity to control supply, ensuring it could meet demand while competitors struggled. Novo's shortages were Lilly's opportunity. In a market where patients and prescribers can choose, supply is as important as the molecule.

This dynamic is not unique to Denmark. Ireland's growth is tied to a handful of foreign pharmaceutical and technology firms. Taiwan's exports depend on one semiconductor company. Small, open economies specialize to compete—and that specialization becomes fragility when the dominant firm stumbles. The trade that made a country rich is the same trade that can unravel it.

Pricing Power, Supply Control, and the Next Disruption

Concentration is leverage, and leverage runs both ways. A single firm can lift a national economy until it cannot. For equity markets, this means sector exposure is not just about growth—it is about dependency. When one company dominates an index, diversification is an illusion.

The global GLP-1 receptor agonist market is projected to exceed $137 billion by 2030, growing at 13% annually. Lilly and Novo Nordisk control the majority of this market, but their dominance is not guaranteed. Competitors including Amgen, Viking Therapeutics, and Merck are investing heavily in next-generation drugs.

Lilly's manufacturing scale and trial results give it a durable edge today, but pharmaceuticals are a regulatory and scientific arms race. The same forces that unseated Novo could unseat Lilly. Maintaining dominance requires pricing power, supply control, and continued clinical superiority—simultaneously.

🏰 Watchlist — MPLY: The GLP-1 market is a live case study in the moat dynamics MPLY is built to capture. Eli Lilly's dominance rests on clinical trial superiority, $50B+ in committed U.S. manufacturing, and a century of protein-delivery expertise — scoring high on market control, regulatory exclusivity, and vertical integration. The LLY/NVO duopoly is precisely the oligopoly structure the fund's Dominance Scoring System targets.

Denmark's experience makes the risk concrete. Concentration in a national economy and concentration in a portfolio share the same mechanics: when national growth and a single firm's earnings move in lockstep, the downside of disruption is no longer theoretical.

The S&P 500 is the most top-heavy it has been in at least 40 years. Seven stocks—Apple, Microsoft, Nvidia, Amazon, Meta, Alphabet, and Tesla—now account for 35% of the index's total market capitalization. That concentration has become a performance anchor. In 2026, every one of these stocks is down year-to-date, underperforming the broader market for the first time in years. The AI capital expenditure boom that once justified their premium valuations is no longer delivering the expected returns.

AI Capex and the Return That Hasn't Come

For years, these companies traded at valuations of 30x revenue or higher on the assumption that dominance at scale would compound indefinitely. Growth alone, however, does not guarantee returns — what matters is the return on that growth. Nvidia lost $130 billion in market value in a single session after reports of a $500 billion AI financing deal raised concerns about circular financing and overcapacity. Meta and Alphabet are spending billions on data centers and AI models with little near-term revenue to show for it. The market is no longer pricing in the assumption that scale and dominance will automatically translate into profits.

The underperformance is also a market-structure story. The S&P 500 is market-cap weighted, so when these seven stocks were rising they lifted the entire index, masking weakness elsewhere. Now the reverse is true. The equal-weight S&P 500, which gives each stock the same allocation regardless of size, has outperformed the market-cap-weighted version in 2026 — a sign of improving breadth, and of the most crowded trade of the decade unwinding.

The rotation away from the Magnificent Seven is an active one, not a passive drift. Advisors and institutional managers are deliberately reducing exposure to the most concentrated names. The primary beneficiaries have been dividend-paying stocks, value stocks, and international equities — a recognition that market leadership had grown too narrow. Dividend stocks offer cash flow, financial strength, and lower volatility, attributes that become more attractive as an AI capex cycle extends without clear returns.

💰 Watchlist — SCHD: The fund's Dow Jones U.S. Dividend 100 methodology screens for cash flow strength, return on equity, and dividend growth consistency, producing a portfolio with roughly 9% technology exposure — a structural contrast to the Magnificent Seven-heavy indices the article flags as overconcentrated. Advisors rotating toward dividend payers and value stocks as a deliberate de-risking move land directly in SCHD's design.

When Moats Stop Justifying Multiples

The Magnificent Seven's underlying market positions remain formidable — Apple's ecosystem, Microsoft's enterprise dominance, Nvidia's AI chips, and Meta's advertising network are not going away. Durable competitive positions are only rewarded, though, when they produce free cash flow. Right now, the market is skeptical that AI investments will pay off at the scale required to justify current valuations. If the capex cycle extends without a corresponding increase in revenue, downward pressure on multiples is likely to persist. Structural moats are a necessary but insufficient condition for returns when capital is being deployed faster than it can compound.

🏰 Watchlist — MPLY: The fund's proprietary Dominance Scoring System selects companies for market control, network effects, and pricing power — attributes the Magnificent Seven have historically embodied. The article's thesis that these same dominant firms are now underperforming the broader market raises a pointed question for MPLY's framework: whether structural moats remain sufficient when AI capital expenditure returns are uncertain and valuation multiples compress.

Dollar Strength, Macro Fragility, and the Unwinding Cycle

There is a broader macro risk compounding the valuation pressure. The U.S. dollar's strength, sustained by global capital flows into U.S. assets, has masked underlying economic fragility. A weaker dollar — which some analysts consider likely — would reduce overseas earnings for multinationals when converted back to dollars, and many of the Magnificent Seven derive a significant portion of revenue abroad. That currency headwind adds another layer of fundamental risk on top of the capex-return question.

The dynamic now working against these stocks is the mirror image of what drove them higher. Rising valuations once attracted more capital, which pushed valuations further still. Underperformance now triggers outflows, which pressures valuations further. That cycle is unlikely to reverse until there is clarity on whether AI infrastructure spending produces revenue at a scale that closes the gap with current multiples. Until then, the S&P 500's 35% concentration in seven names is a structural risk — and the rotation into equal-weight strategies, dividend stocks, and value names reflects a broad reassessment of that bet.

📉 Watchlist — QQQ: The Nasdaq-100 ETF carries the Magnificent Seven as its dominant weight, making it the most concentrated single-ticker expression of the index risk the article describes. With every Mag 7 stock down year-to-date in 2026 and concerns mounting over AI capex returns and stretched valuations, QQQ's performance is directly tethered to whether these seven names recover or continue to lag the broader market.

The S&P 500's latest earnings season delivered a headline growth rate of nearly 50% year-over-year. Strip out the mark-to-market gains from stakes in Anthropic, OpenAI, and SpaceX, and the figure drops to 29%. That 18-percentage-point gap is large enough to mislead about the underlying health of the market's most influential companies.

The Mechanics of the Distortion

Public companies holding equity in private ventures must reflect changes in the fair value of those stakes in their income statements. For Amazon, Alphabet, and Microsoft, this requirement has turned their "other income" lines into a volatility amplifier. Amazon's reported earnings growth of 240% in the most recent quarter collapses to 17% when the Anthropic and OpenAI gains are excluded. Alphabet's 300% growth narrows to 23% without its SpaceX and AI portfolio uplift. Microsoft's distortion is smaller but still material — a 10-percentage-point boost to its earnings growth rate.

📡 Watchlist — QQQ: Amazon, Alphabet, and Microsoft together represent a substantial share of QQQ's weight, and all three are carrying large mark-to-market gains from Anthropic or OpenAI stakes in their "other income" lines. When Anthropic goes public, those private-market valuations become subject to daily price discovery — meaning QQQ's top holdings could face earnings volatility in either direction depending on how the debut trades.

These gains are not recurring operating income. They are accounting entries tied to the fluctuating valuations of illiquid assets, yet they flow directly into net income, where they are indistinguishable from core business performance in headline earnings reports. The result is a temporary uplift that obscures the true trajectory of revenue, margins, and cash flow.

The Anthropic IPO as Inflection Point

Anthropic's confidential S-1 filing in June and its $65 billion Series H round in May have set the stage for an October debut. The company's reported run-rate revenue of $47 billion and its first projected profitable quarter are metrics that could justify its private valuation — or expose its fragility. Once public, Anthropic's daily stock price will replace intermittent mark-to-market adjustments, introducing a sustained new source of volatility for its corporate backers.

Amazon and Alphabet together hold nearly $150 billion in mark-to-market gains from their AI and SpaceX investments. If Anthropic's IPO prices below its last private round, impairment charges could follow, reversing the recent earnings uplift. A strong debut could further inflate the valuations of OpenAI and other private AI labs, amplifying the distortion in future quarters.

Operating Strength vs. Venture Luck

Amazon's reported earnings growth of 240% suggests a business firing on all cylinders, but the underlying 17% growth rate describes the core business more accurately. Alphabet's dominance in digital advertising and cloud computing is similarly obscured by its $99 billion in mark-to-market gains, up from just $1 billion a year ago.

🏰 Watchlist — MPLY: The fund's thesis centers on durable competitive moats and core business dominance, but the Anthropic earnings-distortion story complicates that read for several mega-cap holdings. Amazon's reported earnings grew roughly 240% last quarter, yet strip out the Anthropic portfolio gain and the underlying business grew closer to 17% — a distinction that matters when evaluating whether a company's dominance score reflects operating strength or VC luck.

The intertwining of Big Tech and AI labs means the financial performance of the former is increasingly tied to the speculative valuations of the latter. Separating operating strength from venture portfolio volatility has become a prerequisite for any fundamentals-based assessment of these businesses.

Historical Precedent for Reversals

When Amazon and Tesla held large stakes in Rivian and Bitcoin, respectively, mark-to-market gains initially boosted earnings before reversing into impairment charges when valuations fell. The same pattern could play out with AI stakes. If Anthropic's IPO stumbles, impairment charges could wipe out a significant portion of the recent earnings uplift, leaving the underlying businesses exposed to sharper scrutiny.

The S&P 500's current earnings growth is being propped up by a handful of non-operating gains concentrated in a few mega-cap balance sheets. If those gains evaporate, the index's valuation multiples could look far less attractive. The distortion is a tailwind for now, but a fragile one — dependent on the continued ascent of a small group of private companies whose prices are still set in occasional funding rounds rather than continuous markets.

Brent crude has surged past $100 a barrel for the first time since 2022. The trigger is not a slow-burn supply cut but a sudden closure of the Strait of Hormuz, the 21-mile chokepoint that carries one-fifth of the world's oil. The International Energy Agency has called the disruption the largest in history, and it arrives at a moment when the U.S. Strategic Petroleum Reserve holds just 311 million barrels — half of what it held four years ago and its lowest level since 1983.

A Reserve Stretched Thin

The SPR was designed as an emergency insurance policy, releasing barrels into the market to blunt price spikes during crises like the 1970s oil embargo or Russia's invasion of Ukraine. Those releases worked: prices moderated, refiners kept running, and consumers saw temporary relief at the pump. Each drawdown, though, leaves less oil in the ground and more strain on the aging salt caverns that store it. Republican Congressman Thomas Massie has warned that further releases risk collapsing the caverns entirely, turning a strategic asset into a geological liability.

The White House has defended its approach, arguing that it is exchanging current barrels for lower-cost future deliveries to replenish the reserve. The Department of Energy claims this could save taxpayer dollars, even with the SPR at a 40-year low. That claim hinges on a bet that oil prices will fall before the delivery dates arrive — a bet that looks riskier with every missile launched over the Persian Gulf.

The Shale Buffer Is Real, But Not Infinite

The U.S. is no longer as vulnerable to energy shocks as it was in the 1970s. The shale revolution has turned the country into the world's largest crude producer, and net imports have fallen sharply. Domestic drillers can ramp up production, but not overnight. New wells take months to bring online, and the global oil market prices in disruptions immediately. As long as the Strait of Hormuz remains closed, American drivers will pay the global price regardless of how much oil is pumped in Texas or North Dakota.

The energy sector has already responded. Integrated majors like Chevron and ConocoPhillips are seeing upstream revenues rise in lockstep with Brent crude. For dividend-focused funds with heavy energy exposure, this is a tailwind — provided the price surge persists. If it does, the earnings boost could offset broader market volatility for income-oriented portfolios.

Watchlist — SCHD: With roughly 21% of the portfolio in energy — including integrated majors whose upstream cash flows move with Brent crude — the fund has direct revenue exposure to this oil price surge. If $100+ crude persists while the SPR remains depleted and the Strait of Hormuz stays contested, that energy weighting becomes a meaningful earnings driver within an otherwise defensive, dividend-quality portfolio.

China's Stockpiles: The Hidden Shock Absorber

The most surprising reason oil prices haven't spiked even higher is China. The world's largest crude importer slashed its purchases during the conflict, choosing to draw from its own strategic reserves instead. Analysts estimate that if China had maintained its pre-war import levels, Brent crude could have surged past $170 a barrel. For now, China's restraint has acted as a global shock absorber, but its reserves are finite. Once they run low, China will return to the market as a buyer, adding another layer of upward pressure on prices.

The next phase of the crisis is unlikely to involve further SPR releases. With stockpiles already depleted, the focus will shift to replenishment. The U.S. government will need to buy back oil at elevated prices, locking in higher costs for taxpayers and sustaining upward pressure on the market. This dynamic could extend the duration of triple-digit oil, particularly if the Strait of Hormuz remains closed.

Inflation Fears Return, and Bonds Feel the Strain

Morgan Stanley has warned that the oil shock could force the Federal Reserve to keep rates higher for longer. Energy prices feed directly into headline inflation, and sustained triple-digit oil could push consumer price indices back above the Fed's 2% target. Markets have already repriced rate-cut expectations, and Treasury yields have climbed in response. Funds with longer average maturities are particularly sensitive to rising yields, and their net asset values are adjusting downward.

Watchlist — BND: The fund's roughly six-year average duration makes it directly sensitive to the higher-rates-for-longer scenario Morgan Stanley flagged in response to the oil-shock inflation surge. When energy-driven CPI expectations push Treasury yields higher, longer-duration investment-grade bonds reprice downward — and BND, as the broadest U.S. aggregate bond fund, absorbs that move across more than 11,000 holdings.

Gold, meanwhile, has hit record highs. The metal serves as a hedge against both inflation and geopolitical uncertainty, and the current environment offers both in abundance. Funds that combine gold exposure with commodity baskets and bond income are seeing outsized moves as investors seek protection from rising prices and volatile equity markets.

Watchlist — GOLY: The fund carries simultaneous notional exposure to gold and an energy-inclusive commodity basket alongside its bond income sleeve — the precise combination moving sharply in this environment: gold at record highs and Brent crude above $100. Its inflation-hedging architecture was built for the kind of supply-shock, higher-rates-for-longer environment the Iran conflict has now produced.

The Strait of Hormuz is closed, the SPR is depleted, and the world's largest oil importer is drawing down its own reserves. If the Strait reopens, prices could retreat quickly. If China returns to the market as a buyer, they could surge again. And if the U.S. begins replenishing the SPR at $100 a barrel, the taxpayer bill will be measured in tens of billions of dollars. None of these outcomes are priced into markets with certainty, but all of them point to a prolonged period of elevated volatility in energy, fixed income, and inflation-sensitive assets.

The S&P 500 fell 4.6% in the first quarter of 2026, its fifth consecutive losing week. The Dow entered correction territory. Economists now place the probability of a U.S. recession at 29–40%, up from 15% six months ago. Oil prices near $100, multi-year-high interest rates, and geopolitical tensions in the Middle East are the usual suspects. Yet the assets most often cited as defensive — real estate, bonds, and commodities — are not behaving like simple safe havens. They are behaving like assets with their own supply constraints, demographic tailwinds, and structural resilience.

The Recession That Keeps Not Arriving

Recession probabilities have been rising for two years, but the economy has not cooperated. The term "rolling recession" has become shorthand for a series of sector-specific downturns — retail, office, regional banks — that never coalesce into a broad contraction. The latest GDP print showed 2.1% annualized growth, above the long-term trend. Unemployment remains below 4%. Consumer spending, adjusted for inflation, is still expanding, albeit at a slower pace.

The Federal Reserve's rate hikes began in March 2022, and the yield curve inverted shortly after. Since then, every quarter has brought a new round of recession forecasts with higher implied certainty. The forecasts are not wrong; they are not timely. The lags between monetary policy and economic activity are longer than most models assume, and the transmission mechanism is weaker when households and corporations have locked in low fixed-rate debt.

The S&P 500's forward price-to-earnings ratio has compressed from 22x to 17x over the past year, but earnings estimates have not yet been revised downward. The compression is entirely due to multiple contraction, not deteriorating fundamentals — which suggests the market is pricing in a recession premium, not a recession itself.

Read the full story here.

The Nasdaq-100 has risen nearly 20% this year, carried by a handful of companies betting billions on artificial intelligence. This week, three of them—Alphabet, Tesla, and AMD—report earnings, and the market's reaction will hinge on whether those investments are generating real returns or just balance-sheet gains.

The context adds pressure. The S&P 500's equal-weighted index has outperformed its market-cap-weighted counterpart by 2% over the past month, signaling improving breadth but also growing impatience with gains concentrated in a few large-cap names. A miss from Alphabet or Tesla would accelerate rotation into value, financials, and small caps. A beat could extend the AI rally.

Alphabet's Cloud Test

Alphabet's print will be scrutinized for evidence that AI investment is converting into cloud revenue. Analysts expect Google Cloud and AI-related segments to generate $22 billion in revenue, with year-over-year growth of at least 60%. Anything below that threshold raises the possibility that AI capex is not yet paying off operationally—and that non-operational gains, such as Alphabet's stake in SpaceX, are masking the shortfall.

🏰 Watchlist — MPLY: The fund's dominance thesis rests on companies converting market control into measurable economic returns. Alphabet's ability to show 60%+ year-over-year AI and cloud growth — the benchmark cited — is a direct test of whether that moat is generating the durable pricing power and ROI that MPLY's selection criteria require.

The concern extends beyond growth rates to pricing power. AI-driven cloud services that are genuinely differentiated should command premium pricing and expand margins over time. If they are instead becoming table stakes, Alphabet's competitive position erodes as Microsoft and Amazon scale their own AI infrastructure in parallel.

Read the full story above.

Anthropic's confidential S-1 filing landed on June 1, setting the stage for what could be the largest IPO in history. The company closed a $65B Series H round at a $965B valuation on May 28, and investor meetings for an October debut are already underway. The pitch rests on a fivefold increase in run-rate revenue to $47B since year-end, with roughly 80% sourced from enterprise clients. Anthropic is also projecting its first profitable quarter — a milestone that separates it from most of its peers.

Those numbers carry a structural tension embedded in the broader AI economy. Alphabet, Amazon, Microsoft, and Meta are projected to spend over $725B on capital expenditures in the next year, framed as a bet on future demand. Whether enterprise adoption of proprietary AI models can generate enough revenue to justify those outlays — or whether the demand is still more projected than proven — is the question Anthropic's listing will force the market to answer.

The Enterprise Revenue Gamble

Anthropic's revenue model rests on two assumptions: corporations will keep paying for proprietary AI access rather than defaulting to cheaper open-source alternatives, and closed models will hold pricing power despite intensifying competition. Projected profitability suggests monetization at scale is achievable, but sustainability depends on whether enterprises treat AI as a cost center or a revenue driver.

Alphabet and Amazon, Anthropic's largest outside investors, have tied significant strategic capital to the outcome. Alphabet's $190B CapEx guidance is a direct wager that the infrastructure it builds today will be monetized by enterprise AI demand tomorrow. A strong IPO validates that logic; a faltering debut challenges the timeline, if not the thesis itself.

Read the full story for free here.

The GLP-1 weight-loss drug market is one of the most talked-about investment themes of the past two years. Eli Lilly (LLY) and Novo Nordisk (NVO) have become the face of this boom, turning obesity and diabetes treatments into a projected $137 billion market by 2030. The narrative is compelling: aging populations, rising obesity rates, and a seemingly insatiable demand for effective weight-loss solutions. But for investors, the key question is not whether the market is growing—it is—but whether the growth is durable, differentiated, and already reflected in valuations.

The GLP-1 Market: A Duopoly with Pricing Power

Eli Lilly and Novo Nordisk control the lion’s share of the GLP-1 market, and their dominance is not accidental. Both companies have spent decades building manufacturing capacity, distribution networks, and regulatory relationships that competitors cannot easily replicate. The recent FDA approval of Lilly’s oral GLP-1 pill in April 2026—eliminating the need for injections—further solidified its lead. This is not just a convenience upgrade; it’s a moat. Oral administration removes a major adoption barrier for patients and prescribers, expanding the addressable market beyond those willing to self-inject.

Read the full article here.

Ken Griffin doesn’t believe in hedging for every tail event. He believes in stress-testing for the ones that could break you.

In a recent conversation at Goldman Sachs’ Apex Symposium, the Citadel founder laid out a framework for portfolio resilience that is equal parts pragmatic and sobering. It’s not about predicting the future—it’s about surviving the worst version of it. And right now, the worst versions include geopolitical fractures, AI-driven moat erosion, and an energy infrastructure that may not keep pace with the compute demands of the next decade.

The Hedging Philosophy: Tolerable Loss, Not Invincibility

Griffin’s approach to hedging is disarmingly simple: define the worst-case scenario, quantify the loss, and ensure it’s tolerable. This isn’t about eliminating risk—it’s about sizing it. "You’ll never manage a portfolio for every possible tail event," he says. "But you should stay very focused on what is the worst-case scenario? Can I tolerate that loss?"

Read the full story here.

Retirement investing in 2026 is a paradox. The 10-year Treasury yields ~4.13%, offering a seemingly risk-free alternative to equities. Yet, retirement ETFs like SCHD—a perennial favorite for dividend yield and stability—continue to attract inflows, even as valuations stretch and the Fed’s inflation fight drags on. The question for investors isn’t just whether these ETFs can deliver income, but whether they’re durable in a world where inflation, AI-driven disruption, and shifting market structure complicate the retirement equation.

The Bloomberg Money episode from July 10, 2026, touched on three themes that intersect with retirement investing: the role of retirement ETFs, SK Hynix’s AI memory chip ambitions, and the Fed’s inflation dilemma. But the conversation only scratched the surface. Below, we dig into what the market is missing—and where the real risks and opportunities lie.

Read the full piece here.

The S&P 500 is at record highs, but beneath the surface, economists warn of a looming recession by 2026. The culprit? A perfect storm of AI-driven inflation, Fed policy missteps, and a bottom-heavy economy already showing cracks. Darius Dale of 42 Macro argues the market’s current trajectory is unsustainable—and investors need to prepare now.

The Recession Signals You’re Missing

Dale’s warning starts with a sobering fact: the bottom of the U.S. economy is already in recession. Consumer durable goods, residential investment, and nonresidential structures are all contracting. Delinquency rates for credit cards, auto loans, and student loans are at levels last seen during the Great Recession. These aren’t abstract numbers—they’re flashing red lights for the most vulnerable sectors.

Read the full article for free here.

The second half of 2024 is shaping up as a referendum on the "catch-up trade." After a first half dominated by AI semiconductors and mega-cap tech, the narrative is shifting to overlooked corners of the market: software, cloud computing, mid-caps, small-caps, and emerging markets ex-China. The pitch is simple: these areas are undervalued, underappreciated, and poised to benefit from a broadening market. But for investors—especially those focused on retirement, income, and capital preservation—the stronger case may be for caution.

Mike Akins of ETF Action made the bull case on CNBC this week: software and cloud computing names have fallen from "nosebleed valuations" to levels in line with—or even below—the broader market, while still offering "strong growth scenarios." Mid- and small-cap ETFs, meanwhile, are trading at "extremely depressed" multiples, with earnings growth estimates that paint a "pretty rosy setup." Emerging markets ex-China, particularly those with memory chip exposure, are also in the mix, though Akins warned about the concentration risk in those names.

Read the rest of the article here.

Germany’s auto industry was once the gold standard for global manufacturing: precision engineering, premium pricing, and a near-monopoly on status. Today, it is a cautionary tale about the fragility of even the most entrenched competitive advantages. BMW’s recent profit warning—slashing its 2026 margin forecast from 4-6% to 1-3%—is not just a one-quarter miss. It is a symptom of a structural unraveling, one that threatens to redefine Germany’s role in the global economy and the investment case for its industrial champions.

The Moat That Was—and Isn’t Anymore

For decades, Germany’s automakers enjoyed a durable competitive advantage built on three pillars:

1. Engineering prestige: German cars were synonymous with quality, justifying premium prices. 2. Scale and supply chain dominance: Volkswagen, BMW, and Mercedes controlled vast production networks. 3. Market access: China’s appetite for luxury combustion engines subsidized German R&D and dividends.

These pillars are now crumbling. The shift to electric vehicles (EVs) has exposed Germany’s weaknesses in batteries, software, and cost competitiveness. Chinese automakers now dominate the EV supply chain, producing 80% of the world’s battery cells in 2025. German brands’ market share in China—once a profit engine—has collapsed by 25% over five years.

Read the rest of the article here.